Patent Assignment
Reel/Frame 067680/0831
Assignment of Assignor's Interest
Recorded: 2024-06-10
Pages: 62
Assignor
INHIBRX, INC.
Executed: 2024-05-28
Assignee
INHIBRX BIOSCIENCES, INC.
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA, CALIFORNIA, 92037
Covered Properties
(40)
CD47 Antibodies and Methods of Use Thereof
PCT:
PCT/US2013/024995 ↗
Non-Platelet Depleting and Non-Red Blood Cell Depleting CD47 Antibodies and Methods of Use Thereof
PCT:
PCT/US2013/053818 ↗
Non-Immunogenic Single Domain Antibodies
PCT:
PCT/US2016/014296 ↗
Type Iii Secretion System Targeting Molecules
PCT:
PCT/US2016/030429 ↗
Multivalent and Multispecific DR5-Binding Fusion Proteins
PCT:
PCT/US2016/042862 ↗
Multivalent and Multispecific Gitr-Binding Fusion Proteins
PCT:
PCT/US2016/043717 ↗
Multivalent and Multispecific 41BB-Binding Fusion Proteins
PCT:
PCT/US2017/013040 ↗
Multivalent and Multispecific OX40-Binding Fusion Proteins
PCT:
PCT/US2017/013070 ↗
Multispecific Polypeptide Constructs Having Constrained CD3 Binding and Methods of Using the Same
PCT:
PCT/US2018/027195 ↗
Multispecific Polypeptide Constructs Having Constrained CD3 Binding and Related Methods and Uses
PCT:
PCT/US2019/026860 ↗
Multispecific Polypeptide Constructs Containing a Constrained CD3 Binding Domain and a Receptor Binding Region and Methods of Using the Same
PCT:
PCT/US2019/043115 ↗
OX40-Binding Polypeptides and Uses Thereof
PCT:
PCT/US2019/046156 ↗
B7H3 Single Domain Antibodies and Therapeutic Compositions Thereof
PCT:
PCT/US2019/055427 ↗
DLL3 Single Domain Antibodies and Therapeutic Compositions Thereof
PCT:
PCT/US2019/055436 ↗
5T4 Single Domain Antibodies and Therapeutic Compositions Thereof
PCT:
PCT/US2019/055454 ↗
Pd-1 Single Domain Antibodies and Therapeutic Compositions Thereof
PCT:
PCT/US2019/055929 ↗
Polypeptides Comprising Modified Il-2 Polypeptides and Uses Thereof
PCT:
PCT/US2020/012296 ↗
CD123-Binding Polypeptides and Uses Thereof
PCT:
PCT/US2020/030968 ↗
CD33-Binding Polypeptides and Uses Thereof
PCT:
PCT/US2020/030969 ↗
CLEC12A-Binding Polypeptides and Uses Thereof
PCT:
PCT/US2020/030970 ↗
CD33 Targeted Immunotherapies
PCT:
PCT/US2020/031780 ↗
Cll-1 Targeted Immunotherapies
PCT:
PCT/US2020/031781 ↗
CD123 Targeted Immunotherapies
PCT:
PCT/US2020/031794 ↗
CD28 Single Domain Antibodies and Multivalent and Multispecific Constructs Thereof
PCT:
PCT/US2021/015590 ↗
Canine Pd-1-Binding Polypeptides and Uses Thereof
PCT:
PCT/US2021/030476 ↗
Polypeptides Comprising Modified Il-2 Polypeptides and Uses Thereof
PCT:
PCT/US2021/040061 ↗
Formulations of DR5 Binding Polypeptides
PCT:
PCT/US2022/016935 ↗
CD8-Binding Polypeptides and Uses Thereof
PCT:
PCT/US2022/073877 ↗
CD8-Targeted Modified Il-2 Polypeptides and Uses Thereof
PCT:
PCT/US2022/073878 ↗
NKP46-Binding Polypeptides and Uses Thereof
PCT:
PCT/US2022/075581 ↗
NKP46-Targeted Modified Il-2 Polypeptides and Uses Thereof
PCT:
PCT/US2022/075583 ↗
Gamma Delta T-Cell-Targeted Modified Il-2 Polypeptides and Uses Thereof
PCT:
PCT/US2023/060073 ↗
Gamma Delta T-Cell-Binding Polypeptides and Uses Thereof
PCT:
PCT/US2023/060074 ↗
DR5 Agonist and PLK1 Inhibitor or Cdk Inhibitor Combination Therapy
PCT:
PCT/US2023/065489 ↗
Siglec-8 Binding Proteins and Uses Thereof
PCT:
PCT/US2023/066086 ↗
Albumin-Binding Polypeptides and Uses Thereof
PCT:
PCT/US2023/066580 ↗
DR5 Agonist and Iap Antagonist Combination Therapy
PCT:
PCT/US2023/067279 ↗
Fcrn-Binding Polypeptides and Uses Thereof
PCT:
PCT/US2023/068168 ↗
OX40 Agonist Therapy
PCT:
PCT/US2023/073279 ↗
OX40 Agonist Therapy
PCT:
PCT/US2024/016505 ↗
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 12, 2013
From: ECKELMAN, BRENDAN; TIMMER, JOHN; RAZAI, AMIR; DEVERAUX, QUINN
To: INHIBRX LLC
Reel/Frame 030786/0091 →
Assignment of Assignor's Interest
Sep 9, 2013
From: ECKELMAN, BRENDAN; TIMMER, JOHN; RAZAI, AMIR; DEVERAUX, QUINN
To: INHIBRX LLC
Reel/Frame 031161/0548 →
Assignment of Assignor's Interest
Apr 14, 2016
From: ECKELMAN, BRENDAN P.; TIMMER, JOHN C.; DEVERAUX, QUINN
To: INHIBRX LP
Reel/Frame 038281/0055 →
Assignment of Assignor's Interest
Sep 29, 2016
From: TIMMER, JOHN C.; JONES, KYLE S.; RAZAI, AMIR S.; HUSSAIN, ABRAHIM
To: INHIBRX LP
Reel/Frame 039893/0449 →
Assignment of Assignor's Interest
Oct 20, 2016
From: TIMMER, JOHN C.; JONES, KYLE S.; RAZAI, AMIR S.; HUSSAIN, ABRAHIM
To: INHIBRX LP
Reel/Frame 040073/0748 →
Corrective Assignment to Correct the Assignor Field from Katelyn M. Wills to Katelyn M. Willis Previously Recorded on Reel 039893 Frame 0449. Assignor(S) Hereby Confirms the Assignment for the Listed Properties.
Nov 21, 2016
From: WILLIS, KATELYN M.
To: INHIBRX LP
Reel/Frame 041349/0367 →
Assignment of Assignor's Interest
Jun 26, 2017
From: ECKELMAN, BRENDAN P.; TIMMER, JOHN C.; HATA, CHELSIE; JONES, KYLE S.
To: INHIBRX LP
Reel/Frame 042816/0394 →
Assignment of Assignor's Interest
Aug 17, 2017
From: ECKELMAN, BRENDAN P.; TIMMER, JOHN C.; HATA, CHELSIE; JONES, KYLE S.
To: INHIBRX LP
Reel/Frame 043582/0908 →
Assignment of Assignor's Interest
Nov 15, 2017
From: INHIBRX BIOPHARMA, LLC
To: INHIBRX LP
Reel/Frame 044133/0835 →
Assignment of Assignor's Interest
Jan 30, 2018
From: INHIBRX BIOPHARMA, LLP
To: INHIBRX LP
Reel/Frame 044762/0734 →
Merger and Change of Name
May 22, 2018
From: INHIBRX LP; TENIUM THERAPEUTICS, INC.
To: INHIBRX, INC.
Reel/Frame 046215/0084 →
Assignment of Assignor's Interest
Sep 4, 2019
From: RASCON, LUCAS
To: INHIBRX, INC.
Reel/Frame 050267/0097 →
Assignment of Assignor's Interest
Sep 4, 2019
From: RASCON, LUCAS
To: INHIBRX, INC.
Reel/Frame 050265/0685 →
Assignment of Assignor's Interest
Mar 16, 2020
From: PANDIT, RAJAY A.; TIMMER, JOHN C.; SANABRIA, ANGELICA N.; SULZMAIER, FLORIAN
To: INHIBRX, INC.
Reel/Frame 052121/0250 →
Assignment of Assignor's Interest
Jul 1, 2020
From: JACKSON, RUTGER H.
To: INHIBRX, INC.
Reel/Frame 053103/0087 →
Assignment of Assignor's Interest
Jul 1, 2020
From: TIMMER, JOHN C.; KAPLAN, MICHAEL D.; WILLIS, KATELYN M.; PANDIT, RAJAY A.
To: INHIBRX, INC.
Reel/Frame 053103/0136 →
Assignment of Assignor's Interest
Aug 4, 2020
From: JARJOUR, JORDAN; POGSON, MARK; LEUNG, WAI-HANG
To: BLUEBIRD BIO, INC.
Reel/Frame 053395/0484 →
Assignment of Assignor's Interest
Aug 4, 2020
From: JARJOUR, JORDAN; POGSON, MARK; LEUNG, WAI-HANG
To: BLUEBIRD BIO, INC.
Reel/Frame 053395/0309 →
Assignment of Assignor's Interest
Aug 6, 2020
From: JARJOUR, JORDAN; POGSON, MARK; LEUNG, WAI-HANG
To: BLUEBIRD BIO, INC.
Reel/Frame 053417/0078 →
Assignment of Assignor's Interest
Jul 30, 2021
From: JONES, KYLE; CRAGO, WILLIAM; SANABRIA, ANGELICA; HOLLANDS, ANDREW
To: INHIBRX, INC.
Reel/Frame 057044/0866 →
Assignment of Assignor's Interest
Jul 30, 2021
From: RASCON, LUCAS; SANABRIA, ANGELICA; TIMMER, JOHN C.; ECKELMAN, BRENDAN P.
To: INHIBRX, INC.
Reel/Frame 057044/0876 →
Assignment of Assignor's Interest
Jul 30, 2021
From: MACEDO, CHELSIE; JONES, KYLE; CRAGO, WILLIAM; HOLLANDS, ANDREW
To: INHIBRX, INC.
Reel/Frame 057044/0854 →
Assignment of Assignor's Interest
Jul 30, 2021
From: JONES, KYLE; CRAGO, WILLIAM; SANABRIA, ANGELICA; HOLLANDS, ANDREW
To: INHIBRX, INC.
Reel/Frame 057044/0858 →
Assignment of Assignor's Interest
Jul 30, 2021
From: RASCON, LUCAS; SANABRIA, ANGELICA; TIMMER, JOHN C.; ECKELMAN, BRENDAN P.
To: INHIBRX, INC.
Reel/Frame 057044/0862 →
Assignment of Assignor's Interest
Jul 30, 2021
From: MACEDO, CHELSIE; JONES, KYLE; CRAGO, WILLIAM; HOLLANDS, ANDREW
To: INHIBRX, INC.
Reel/Frame 057044/0850 →